PPDI

PPD Declares 12.5 Cent Dividend - 11/11 - 08:34 PM ET

BRIEF-PPD sets dividend - 11/11 - 04:21 PM ET

PPD Chairman of the Board Pledges $5 Million to Rutgers' Ernest Mario School of Pharmacy - 10/29 - 04:24 PM ET

Pharmaceutical Product Development Tests Support - 10/23 - 11:20 AM ET

PPD Lowers Guidnace Inline with Estimates - 10/21 - 04:41 PM ET

PPD Reports Third Quarter 2008 Financial Results; Updates 2008 Financial Guidance - 10/21 - 04:35 PM ET

FDA to Continue Review of Alogliptin NDA - 10/10 - 08:36 AM ET

CSS Informatics Partners with DrugLogic(R) to Offer Clients Faster Access to Clinical Trial Adverse Event Data - 10/09 - 04:06 PM ET

Pharmaceutical Product Development Picks Up Volume, Hits Yearly Low - 10/08 - 12:34 PM ET

PPD Selected as Clinical Development Preferred Provider by Juvenile Diabetes Research Foundation - 10/07 - 04:12 PM ET

PPD Announces Third Quarter 2008 Earnings Release, Webcast and Conference Call - 10/02 - 04:01 PM ET

PPD Completes Acquisition of InnoPharm - 10/01 - 04:29 PM ET

PPD Confirms Takeda's NDA Submission of Alogliptin in Japan - 09/29 - 08:49 AM ET

PPD Confirms Takeda's NDA Submission of Alogliptin and ACTOS(R) to U.S. Food and Drug Administration - 09/24 - 02:03 PM ET

PPD Increases Cash Dividend - 09/18 - 04:43 PM ET

PPD Declares Third Quarter Dividend - 08/27 - 04:10 PM ET

Pharmaceutical Product Development Picks Up Volume, Accelerates Decline - 08/19 - 02:34 PM ET

Pharmaceutical Product Development Sets Nine Month Low - 07/30 - 08:12 AM ET

PPDI: Q2 Earnings Call @ 09:00 ET Today [delayed] - 07/23 - 07:22 AM ET

PPD Reports Second Quarter 2008 Financial Results - 07/22 - 04:20 PM ET

Page 1 of 6     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index